Atypical presentation of eosinophilic endomyocardial disease

Mayo Clinic Proceedings

Volumn 80, Issue 8, 2005, Pages 1078-1084

  Blauwet, Lori A ^a   Breen, Jerome F ^a   Edwards, William D ^a   Klarich, Kyle W ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIFFERENTIAL DIAGNOSIS; ELECTROCARDIOGRAPHY; ENDOCARDIUM; GERIATRIC PATIENT; HEART MUSCLE; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HEART VENTRICLE THROMBOSIS; HUMAN; HYPEREOSINOPHILIC SYNDROME; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; THORAX RADIOGRAPHY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 23244446596     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/80.8.1078     Document Type: Article

References (38)

1. Chusid MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore). 1975;54:1-27.
2. Parrillo JE, Borer JS, Henry WL, Wolff SM, Fauci AS. The cardiovascular manifestations of the hypereosinophilic syndrome: prospective study of 26 patients, with review of the literature. Am J Med. 1979;67:572-582.
3. Schooley RT, Flaum MA, Gralnick HR, Fauci AS. A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome, II: clinical manifestations. Blood. 1981;58:1021-1026.
4. Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH. The idiopathic hypereosinophilic syndrome: clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med. 1982;97:78-92.
5. Spry CJ. The hypereosinophilic syndrome: clinical features, laboratory findings and treatment. Allergy. 1982;37:539-551.
6. Hardy WR, Anderson RE. The hypereosinophilic syndromes. Ann Intern Med. 1968;68:1220-1229.
7. Flaum MA, Schooley RT, Fauci AS, Gralnick HR. A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome, I: hematologic manifestations. Blood: 1981;58:1012-1020.
8. Karnak D, Kayacan O, Beder S, Delibalta M. Hypereosinophilic syndrome with pulmonary and cardiac involvement in a patient with asthma. CMAJ. 2003;168:172-175.
9. Felice PV, Sawicki J, Anto J. Endomyocardial disease and eosinophilia. Angiology. 1993;44:869-874.
10. Solley GO, Maldonado JE, Gleich GJ, et al. Endomyocardiopathy with eosinophilia. Mayo Clin Proc. 1976;51:697-708.
11. Tai PC, Ackerman SJ, Spry CJ, Dunnette S, Olsen EG, Gleich GJ. Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet. 1987;1:643-647.
12. deMello DE, Liapis H, Jureidini S, Nouri S, Kephart GM, Gleich GJ. Cardiac localization of eosinophil-granule major basic protein in acute necrotizing myocarditis. N Engl J Med. 1990;323:1542-1545.
13. Lombardi C, Passalacqua G. Eosinophilia and diseases: clinical revision of 1,862 cases. Arch Intern Med. 2003;163:1371-1373.
14. Leiferman KM, Gleich GJ. Hypereosinophilic syndrome: case presentation and update. J Allergy Clin Immunol. 2004;113:50-58.
15. Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood. 1994;83:2759-2779.
16. Parrillo JE, Fauci AS, Wolff SM. Therapy of the hypereosinophilic syndrome. Ann Intern Med. 1978;89:167-172.
17. Kobayashi S, Inokuma S, Setoguchi K, Kono H, Abe K. Incidence of peripheral blood eosinophilia and the threshold eosinophile count for indicating hypereosinophilia-associated diseases. Allergy. 2002;57:950-956.
18. D'Souza MG, Swistel DG, Castro JL, DeRose JJ Jr. Hypereosinophilic thrombus causing aortic stenosis and myocardial infarction. Ann Thorac Surg. 2003;76:1725-1726.
19. Maruyoshi H, Nakatani S, Yasumura Y, et al. Löffler's endocarditis associated with unusual ECG change mimicking posterior myocardial infarction. Heart Vessels. 2003;18:43-46.
20. Kabbani SS, LeWinter MM. Diastolic heart failure: constrictive, restrictive, and pericardial. Cardiol Clin. 2000;18:501-509.
21. Arnold M, McGuire L, Lee JC. Loeffler's fibroplastic endocarditis. Pathology. 1988;20:79-82.
22. Ommen SR, Seward JB, Tajik AJ. Clinical and echocardiographic features of hypereosinophilic syndromes. Am J Cardiol. 2000;86:110-113.
23. Eroglu E, Di Salvo G, Herbots L, Herregods MC, Sutherland GR. Restrictive left ventricular filling in hypereosinophilic syndrome as a result of partial cavity obliteration by an apical mass: a strain/strain rate study. J Am Soc Echocardiogr. 2003;16:1088-1090.
24. Puvaneswary M, Joshua F, Ratnarajah S. Idiopathic hypereosinophilic syndrome: magnetic resonance imaging findings in endomyocardial fibrosis. Australas Radiol. 2001;45:524-527.
25. Mollet NR, Dymarkowski S, Volders W, et al. Visualization of ventricular thrombi with contrast-enhanced magnetic resonance imaging in patients with ischemic heart disease. Circulation. 2002;106:2873-2876.
26. Bishop GG, Bergin JD, Kramer CM. Hypereosinophilic syndrome and restrictive cardiomyopathy due to apical thrombi. Circulation. 2001;104:E3-E4.
27. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992-2002.
28. Priglinger U, Drach J, Ullrich R, Baumgartner H, Huber K, Maurer G. Idiopathic eosinophilic endomyocarditis in the absence of peripheral eosinophilia. Leuk Lymphoma. 2002;43:215-218.
29. De Vriese AS, Kips JC, Vogelaers DP, Vandewoude KH, Cuvelier CA, Colardyn FA. Pitfalls in the diagnosis of hypereosinophilic syndrome: a report of two cases. J Intern Med. 1997;241:165-170.
30. Butterfield JH, Gleich GJ. Interferon-alpha treatment of six patients with the idiopathic hypereosinophilic syndrome. Ann Intern Med. 1994;121:648-653.
31. Baratta L, Afeltra A, Delfino M, De Castro S, Giorgino F, Rossi-Fanelli F. Favorable response to high-dose interferon-alpha in idiopathic hypereosinophilic syndrome with restrictive cardiomyopathy: case report and literature review. Angiology. 2002;53:465-470.
32. Cortes J, Ault P, Koller C, et al. Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome. Blood. 2003;101:4714-4716.
33. Gleich GJ, Leiferman KM, Pardanani A, Tefferi A, Butterfield JH. Treatment of hypereosinophilic syndrome with imatinib mesilate. Lancet. 2002; 359:1577-1578.
34. Garrett JK, Jameson SC, Thomson B, et al. Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol. 2004;113:115-119.
35. Bain BJ. Hypereosinophilia. Curr Opin Hematol. 2000;7:21-25.
36. Moraes CR, Buffolo E, Lima R, et al. Surgical treatment of endomyocardial fibrosis. J Thorac Cardiovasc Surg. 1983;85:738-745.
37. Metras D, Coulibaly AO, Ouattara K, et al. Endomyocardial fibrosis: early and late results of surgery in 20 patients. J Thorac Cardiovasc Surg. 1982; 83:52-64.
38. Arvay A, Lengyel M, Meszaros R, Palik I. Surgical experience with thrombotic and fibrotic forms of non-tropical eosinophilic endomyocardial disease. Thorac Cardiovasc Surg. 1985;33:314-316.